IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells - Sorbonne Université
Journal Articles Journal of Experimental Medicine Year : 2010

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

Abstract

Regulatory T cells (T reg cells) play a major role in controlling the pathogenic autoimmune process in type 1 diabetes (T1D). Interleukin 2 (IL-2), a cytokine which promotes T reg cell survival and function, may thus have therapeutic efficacy in T1D. We show that 5 d of low-dose IL-2 administration starting at the time of T1D onset can reverse established disease in NOD (nonobese diabetic) mice, with long-lasting effects. Low-dose IL-2 increases the number of T reg cells in the pancreas and induces expression of T reg cell-associated proteins including Foxp3, CD25, CTLA-4, ICOS (inducible T cell costimulator), and GITR (glucocorticoid-induced TNF receptor) in these cells. Treatment also suppresses interferon gamma production by pancreas-infiltrating T cells. Transcriptome analyses show that low-dose IL-2 exerts much greater influence on gene expression of T reg cells than effector T cells (T eff cells), suggesting that nonspecific activation of pathogenic T eff cells is less likely. We provide the first preclinical data showing that low-dose IL-2 can reverse established T1D, suggesting that this treatment merits evaluation in patients with T1D.
Fichier principal
Vignette du fichier
jem_20100209.pdf (2.49 Mo) Télécharger le fichier
Origin Publication funded by an institution
Loading...

Dates and versions

hal-02565914 , version 1 (06-05-2020)

Identifiers

Cite

Yenkel Grinberg-Bleyer, Audrey Baeyens, Sylvaine You, Rima Elhage, Gwladys Fourcade, et al.. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. Journal of Experimental Medicine, 2010, 207 (9), pp.1871-1878. ⟨10.1084/jem.20100209⟩. ⟨hal-02565914⟩
71 View
28 Download

Altmetric

Share

More